PRAMODINI MEDICARE LTD Fair Value
PRAMODINI · Healthcare · Current price ₹128
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹159 | 39% ROE fading to 13% over ~10 yrs, on ₹53 book |
| Relative P/E | ₹673 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹111 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is PRAMODINI MEDICARE LTD undervalued?
DocStoX estimates the fair value of PRAMODINI MEDICARE LTD at ₹296 per share, versus the current market price of ₹128. That puts the stock about +131.3% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹159), Relative P/E (₹673), Graham floor (₹111). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹111 (bear) to ₹296 (base) to ₹673 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on PRAMODINI MEDICARE LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.